| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/12/2004 | WO2004012767A1 Medicinal agent and method for curing erectile dysfunction |
| 02/12/2004 | WO2004012764A1 Medicinal agent and method for curing prostate diseases |
| 02/12/2004 | WO2004012754A1 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 02/12/2004 | WO2004012702A1 New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 02/12/2004 | WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof |
| 02/12/2004 | WO2003091259A8 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2002101357A9 Molecular signatures of commonly fatal carcinomas |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040030165 14 Beta, 16, 17-methylene steroids as novel androgens |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040029965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029909 Heat, sulfurization of the corresponding compound with tetraphosphorus tetrasulfide; Parkinson's disease, sexual disorders |
| 02/12/2004 | US20040029900 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 02/12/2004 | US20040029891 Use of PDE5 inhibitors in the treatment of polycystic ovary syndrome |
| 02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040028733 Therapy for fertility disorders; stabilized follicle stimulating hormone |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387690A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP0820288B1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| 02/11/2004 | CN1474700A Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1474692A Treatment of premature ejaculation |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1473840A Gene sequence of rockfish pituitary rich in reproductive control factor and its use |
| 02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
| 02/11/2004 | CN1473613A Chinese medicine for treating gynecopathy |
| 02/11/2004 | CN1473606A Baizhi dehumidizer made from gloden cyllress and cape jasmine etc. Chinese herbal medicines |
| 02/11/2004 | CN1473594A Extract of Maka root |
| 02/11/2004 | CN1473561A Quick-releasing talbet in vagina and its preparing method |
| 02/11/2004 | CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
| 02/11/2004 | CN1137719C Chinese medicine for treating chronic salpingitis |
| 02/11/2004 | CN1137714C Medicinal liquor for treating sexual disfunction and its preparing process |
| 02/11/2004 | CN1137703C Chinese medicinal ointment for treating mastopathy |
| 02/11/2004 | CN1137691C heterogeneous contraception preparation based on natural estrogen |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/10/2004 | CA2164951C Lipoxin compounds |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/05/2004 | WO2004011468A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011416A1 CRYSTALLINE β2 ADRENERGIC RECEPTOR AGONIST |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004011029A2 Pharmaceutical compositions for penis enlargement |
| 02/05/2004 | WO2004011028A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | WO2004011008A1 COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION |
| 02/05/2004 | WO2004011002A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2003089001A8 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2002059373A3 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 02/05/2004 | US20040024231 Such as 17-beta-hydroxy-17-alpha-trifluoromethyl-7-alpha-methyl-androst-4-en-3-one; for hormone replacement therapy |
| 02/05/2004 | US20040024218 Novel compounds |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/05/2004 | US20040024041 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 02/05/2004 | US20040024039 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers |
| 02/05/2004 | US20040024038 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 02/05/2004 | US20040024016 Drug for prevention and/or therapy of endometriosis |
| 02/05/2004 | US20040023991 Use of pyrazolo[4,3-d]pyrimidines |
| 02/05/2004 | US20040023990 Use of pyrazolo[4,3-d]pyrimidines |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |